Panel discussion on personalizing early diagnosis of #biliarycancer at the ENS-CCA Precision-BTC-Network meeting in Krakow Rocío IR Macías chiara braconi Chiara Gabbi Liver Growth and Cancer Lab Lewis Roberts Jesus Bañales Alejandro Forner Pedro Rodrigues

🔥off the press: Whole-exome sequencing reveals novel cancer genes & actionable targets in biliary tract cancers in PSC Hepatology Communications doi.org/10.1097/HC9.00… 👉Interesting data on molecular underpinnings of PSC- CCA 😅more to come, stay tuned.. EASLnews ESMO - Eur. Oncology ILCA

❓What are the predictors of aggressive recurrence of HCC after resection? Journal of Hepatology ➡️Aggressive recurrence: exceeding the Milan criteria at 1st recurrence 🚨35% ❗️Microvascular invasion and/or satellitosis is the only independent risk factor for aggressive recurrence

A breakthrough for refractory autoimmune diseases has been engineering patient's T cells to target CD-19. Now the first use of an off-the-shelf product is reported to work well in a few patients cell.com/cell/abstract/… Cell

📢¡Novedades! Te presentamos la imagen para nuestro 50º Congreso Anual, que coincide también con nuestro 50 Aniversario, en 2025. 📅Habrá un día más de Congreso, del 25 al 28 de febrero en el Hotel Melia_Castilla de #Madrid. Atentos porque pronto daremos más información. ¡Será

Do early tacrolimus levels impact HCC recurrence? journals.lww.com/lt/abstract/99…

Elliot Tapper ➡️ Saying that this is the end for sec prophylaxis of SBP is a big saying!Surveys where 50% of pts receive treatment and the rest not, do not provide the same quality of information as a RCT! 😱 ✅ As JP Benhamou used to say, “when I don’t know what is best, I randomize”

Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC - JHEP Reports jhep-reports.eu/article/S2589-…

Happy to share our manuscript Liver stiffness measurement predicts clinical outcomes in autoimmune h... sciencedirect.com/science/articl… ☑️ LSM >8.5 predicts cirrhosis and liver-related outcomes in AIH JHEP Reports Asociación Española para el Estudio del Hígado Álvaro Díaz-González Mar Riveiro EASLnews

Excited for the participation of the Clinic Barcelona Comprehensive Cancer Center at #ESMO24 ! Hospital Clínic IDIBAPS Universitat de Barcelona Our investigators contributing to 35 studies: ✅ 1 Presidential Symposium ✅ 4 Proffered Paper Presentations ✅ 7 Mini-oral Presentations ✅

El #CLÍNIC és líder en trasplantaments de fetge a Catalunya: 🔷 Per activitat 🔷 Per supervivència 💪 Per això és centre de referència per a pacients d’alta complexitat i se centra en la innovació constant en tots els àmbits i la #recerca ➕ Info 👉 i.mtr.cool/yazfmqvxje

GLP-1 drugs associated with reduction of cirrhosis and all-cause mortality in participants with MASLD (metabolic-dysfunction associated steatotic liver disease), but without effect in those with pre-existing cirrhosis. jamanetwork.com/journals/jamai… JAMA Internal Medicine Fasiha Kanwal

🇪🇸 formally adopts #GEMA💎 for liver transplant waiting list prioritization to reduce mortality and to improve equity. Paving the way for other countries. Read the full consensus by SETH and Organización Nacional de Trasplantes 👇 pubmed.ncbi.nlm.nih.gov/39267491/